Letter to the Editor
Treatment Preferences among Depressed Patients after Acute Coronary Syndrome: The COPES Observational CohortBurg M.M.a, b · Rieckmann N.c · Clemow L.a · Medina V.a · Schwartz J.a · Davidson K.W.a
aColumbia University School of Medicine, New York, N.Y., and bYale University School of Medicine, New Haven, Conn., USA; cBerlin School of Public Health, Charité University Medical Center, Berlin, Germany
Matthew M. Burg, PhD
Center for Behavioral Cardiovascular Health
Columbia University School of Medicine
630 West 168th Street – PH9, New York, NY 10032 (USA)
Do you have an account?
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.